International Journal of Tuberculosis and Lung Disease

Article	Citations
The impact of COVID-19 on TB: a review of the data	121
The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries	79
Post-tuberculosis lung health: perspectives from the First International Symposium	76
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19	67
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	45
The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis	45
New diseases and old threats: lessons from tuberculosis for the COVID-19 response	37
COVID-19 and tuberculosis—threats and opportunities	36
Impact of COVID-19 on tuberculosis control in China	32
Impact of COVID-19 on TB diagnosis in Northeastern Brazil	32
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China	29
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria	29
Mask wearing to complement social distancing and save lives during COVID-19	28
Air pollution interventions and respiratory health: a systematic review	26
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda	24
The impact of smoking on tuberculosis treatment outcomes: a meta-analysis	23
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review	23
Tuberculosis contact investigation and short-course preventive therapy among young children in Africa	22
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB	22
Post-tuberculosis sequelae: the need to look beyond treatment outcome	22
Tobacco control in China and the road to Healthy China 2030	21
Should we consider a ‘fourth 90’ for tuberculosis?	20
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis	20
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic	19
Clinical standards for the diagnosis, treatment and prevention of TB infection	19

Severe COVID-19 cases with a history of active or latent tuberculosis	19
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape	19
The need for pulmonary rehabilitation following tuberculosis treatment	18
Impact of the global COVID-19 outbreak on the management of other communicable diseases	18
The Global Asthma Report 2022	18
How TB and COVID-19 compare: an opportunity to integrate both control programmes	18
Impact of COVID-19 on tuberculosis services in India	18
Occupational asthma	18
Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis	18
Critical changes to services for TB patients during the COVID-19 pandemic	17
TB and COVID-19 co-infection: rationale and aims of a global study	17
The COVID-19 and TB syndemic: the way forward	17
Adapting TB services during the COVID-19 pandemic in Mumbai, India	17
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial	17
Thrombotic events and COVID-19 vaccines	17
Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid	16
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	16
Asbestos-related diseases	15
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function	15
Resource reprioritisation amid competing health risks for TB and COVID-19	15
Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis	14
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic	13
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities	13
Comparative analysis of Truenat™ MTB Plus and Xpert® Ultra in diagnosing tuberculous meningitis	13
TB and the COVID-19 pandemic: brothers in arms against lung health	13
Mortality due to TB-COVID-19 coinfection in India	13
Clinical standards for the dosing and management of TB drugs	13
Availability of diagnostic services and essential medicines for non‐communicable respiratory diseases in African countries	13
Computer-aided detection for tuberculosis and silicosis in chest radiographs of gold miners of South Africa	13
Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort	12
A global update on rare non-tuberculous mycobacteria in humans: epidemiology and emergence	12
How to demystify COVID-19 and reduce social stigma	12
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine	12
National population-based tuberculosis prevalence survey in Ghana, 2013	12
Evaluation of recorded video-observed therapy for anti-tuberculosis treatment	12
Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?	12
The burden and determinants of post-TB lung disease	12
Tuberculosis from transmission in clinics in high HIV settings may be far higher than contact data suggest	12
WHO drug-resistant TB guidelines 2022: what is new?	11
Automated chest radiography and mass systematic screening for tuberculosis	11
Let us not forget the mask in our attempts to stall the spread of COVID-19	11
Tackling the threat of COVID-19 in Africa: an urgent need for practical planning	11
Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms	11
Person-centred care in TB	11
Bedaquiline for multidrug-resistant TB in paediatric patients	11
Delays and barriers to early treatment initiation for childhood tuberculosis in India	11
TB multimorbidity: a global health challenge demanding urgent attention	11
Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975–2014	10
Sustaining essential healthcare in Africa during the COVID-19 pandemic	10
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini	10

The impact of COVID-19 on the diagnosis of TB in Taiwan	10
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis	10
Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis	10
Policies, practices and barriers to implementing tuberculosis preventive treatment—35 countries, 2017	10
Anthropogenic climate change and health in the Global South	9
Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose	9
Predictive models for COVID-19-related deaths and infections	9
Management of rifampicin‐resistant TB: programme indicators and care cascade analysis in South Africa	9
A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes	9
Serology-positive but minimally symptomatic COVID-19 may still cause lung injury and lung function impairment	9
How to manage children if a second wave of COVID-19 occurs	9
Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs	9
The fourth national anti-tuberculosis drug resistance survey in Peru	9
Risk factors for chronic pulmonary aspergillosis in post-TB patients	9
Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy	9
Patient-cost survey for tuberculosis in the context of patient-pathway modelling	9
Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review	9
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression	9
Evaluating the use of educational videos to support the tuberculosis care cascade in remote Madagascar	9
Geographic distribution, socio-economic disparity and policy determinants of smoke-free policy adoption in Indonesia	9
COPD exacerbation rates are higher in non-smoker patients in India	8
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts	8
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India	8
First molecular-based anti-TB drug resistance survey in Eritrea	8
Real-world implementation of video-observed therapy in an urban TB program in the United States	8
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium	8
Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis	8
Preparing national tuberculosis control programmes for COVID-19	8
Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia	8
Performance of a household tuberculosis exposure survey among children in a Latin American setting	8
Priorities among HIV-positive individuals for tuberculosis preventive therapies	8
The impact of PM2.5 on lung function in adults with asthma	8
Determining the value of TB active case-finding: current evidence and methodological considerations	8
First-line tuberculosis treatment with double-dose rifampicin is well tolerated	8
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil	8
Two parallel pandemics: the challenges faced by countries with COVID-19 and TB	8
Genomic diversity and transmission dynamics of M. tuberculosis in Africa: a systematic review and meta-analysis	8
A comparison of digital chest radiography and Xpert® MTB/RIF in active case finding for tuberculosis	8
Breastfeeding in women living with tuberculosis	8
Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey	8
Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives	8
Post-TB health and wellbeing	8
Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis	7
Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV	7
Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study	7
Multidrug-resistant tuberculosis in the United States, 2011–2016: patient characteristics and risk factors	7
Four of five tuberculosis patients experience catastrophic costs related to TB diagnosis and care in Timor-Leste	7
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia	7
Cost of TB services in healthcare facilities in Kenya (No 3)	7
Tuberculosis patients with higher levels of poverty face equal or greater costs of illness	7
Modelling the potential impact of adherence technologies on tuberculosis in India	7
The largest prison outbreak of TB in Western Europe investigated using whole-genome sequencing	7
Number needed to screen for TB in clinical, structural or occupational risk groups	7
The catastrophic cost of tuberculosis: advancing research and solutions	7
Chronic obstructive pulmonary disease in sub-Saharan Africa	7
Monitoring the COVID-19 pandemic in sub-Saharan Africa: focusing on health facility admissions and deaths	7
Spatial variability in the risk of death from COVID-19 in Italy	7
Determinants of lung health across the life course in sub-Saharan Africa	7
Minimal clinically important difference of the 6-min walking test in patients with asthma	7
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis	7
What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?	7
Opportunities to improve digital adherence technologies and TB care using human-centered design	6
Impact of COVID-19 on patients with asthma	6
TB and TB-HIV care for adolescents and young adults	6
The scientific response to TB – the other deadly global health emergency	6
Challenges in conducting trials for pediatric tuberculous meningitis: lessons from the field	6
An Inca trail to the Holy Grail: digital medication adherence support for TB care	6
Costs of TB services in India (No 1)	6
High yields from contact investigation of child index TB patients	6
Cost savings associated with video directly observed therapy for treatment of tuberculosis	6
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men	6
Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients	6
Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia	6
Respiratory health among office workers in Malaysia and endotoxin and (1,3)-β-glucan in office dust	6
A novel approach for eliciting adolescent MDR-TB treatment tolerability: qualitative data from South Africa	6
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi	6
Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain	6
Vitamin D deficiency is associated with tuberculosis disease in British children	6
Diurnal variability of fine-particulate pollution concentrations: data from 14 low- and middle-income countries	6
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study	5

Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis	5
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	5
Characteristics of a “rebound” in smoking after a tobacco price increase	5
Fluoroquinolone preventive therapy for children exposed to MDR-TB	5
The effect of systematic screening of the general population on TB case notification rates	5
Tuberculosis trends in a hot-spot region in Paris, France	5
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines	5
Xpert® MTB/RIF Ultra performance in diagnosing paediatric pulmonary TB in gastric aspirates	5
Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB	5
Towards quality adolescent-friendly services in TB care	5
Rapid development of a portable negative pressure procedural tent	5
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB	5
Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease	5
A systematic review of the number needed to screen for active TB among people living with HIV	5
Setting up pharmacovigilance based on available endTB Project data for bedaquiline	5
Vitamin D deficiency predicts latent TB reactivation independent of preventive therapy: a longitudinal study	5
Continuity of TB services during the COVID-19 pandemic in China	5
Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes	5
A randomised controlled trial to evaluate a medication monitoring system for TB treatment	5
Cost of TB services in the public and private sectors in Georgia (No 2)	5
Diagnostic yield of sputum induction in patients with pleural tuberculosis at a tertiary care hospital in Karachi	5
Complications of tuberculous meningitis and their effect on outcome in a tertiary care cohort	5
The 100th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19	5
QT prolongation in the STREAM Stage 1 Trial	5
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up	5
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed	5
COVID-19: ensuring continuity of TB services in the private sector	5
Face masks – a sustainable measure to mitigate COVID-19	5
Concern over a COVID-19-related BCG shortage	5
Opportunities to prevent and manage undernutrition to amplify efforts to end TB	5
Effect of bronchial artery embolisation on the management of tuberculosis-related haemoptysis	5
The diagnosis of lung cancer in the era of interventional pulmonology	5
Key changes in the public health response to TB and HIV in South Africa	5
Preventive treatment of drug-resistant TB in a rural setting	4
How Big Tobacco uses disruptive tactics to deny child rights to be tobacco-free	4
Density of cigarette retailers around educational facilities in Indonesia	4
Completion of treatment for latent TB infection in a low prevalence setting	4
Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy	4
Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town	4
Chronic kidney disease, tuberculosis and climate change	4
COVID-19 in Africa: community and digital technologies for tuberculosis management	4
Density of tobacco advertising around schools	4
Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City	4
The Asthma Drug Facility and the future management of asthma	4
Time for a change: considering regimen changes in analyses of observational drug-resistant TB treatment cohort data	4
In Reply: How TB and COVID-19 compare: an opportunity to integrate both control programmes	4
TB in older people in Asia: why it is important	4
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients	4
Clinical standards for drug-susceptible pulmonary TB	4
Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam	4
Impact of influenza A co-infection with COVID-19	4
Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes	4
How mechanistic in silico modelling can improve our understanding of TB disease and treatment	4
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children	4
Using a mobile application to improve pediatric presumptive TB identification in western Kenya	4
Childhood TB in China: notification, characteristics and risk factors for outcomes, 2010–2017	4
Is effective patient support missing in the global response to multidrug-resistant tuberculosis?	4
Tobacco use and quitting behaviour during COVID-19 lockdown	4
Tuberculosis and diabetes mellitus: a dose-response relationship between the odds of tuberculosis and HbA1c	4
COVID-19 and TB: a progression-regression conundrum	4
A public health approach to increase treatment of latent TB among household contacts in Brazil	4
Knowledge, attitudes and practices on childhood TB among healthcare workers	4
Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil	4
Association between chronic airflow obstruction and socio-economic position in Morocco: BOLD results	4
UNITE4TB: a new consortium for clinical drug and regimen development for TB	4
A comparative analysis of asthma treatment guidelines and Essential Medicine Lists in sub-Saharan Africa	4
Seasonality, climate change and tuberculosis: new data and old lessons	4
The war in Ukraine and potential consequences for the TB epidemic in Europe	4
The Bedaquiline Donation Program: progress and lessons learned after 4 years of implementation	4
Disseminated Mycobacterium avium complex infection as a differential diagnosis of tuberculosis in HIV patients	4
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study	4
Quantification of neutrophil and monocyte CD64 expression: a predictive biomarker for active tuberculosis	4
COVID-19 and TB control in immigrant communities	4
VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB	4
The impact of COVID-19 on the TB response: data from the field	4
Effects of comorbidities on quality of life in Filipino people with tuberculosis	4
Helping Africa to breathe when COVID-19 strikes	4
Adipokines and the risk of active TB: a nested case-control study	4
Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility	4
Decreased notification of TB cases during the COVID-19 pandemic	4
Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays	4
Incremental yield of Xpert® MTB/RIF Ultra over Xpert® MTB/RIF in the diagnosis of extrapulmonary TB	3
Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti	3
Changes to TB care in an outpatient centre during the COVID‐19 pandemic	3
TB outcomes and mortality risk factors in adult migrants at the Thailand-Myanmar border	3
How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease	3
Associations between air pollutants and peak expiratory flow and fractional exhaled nitric oxide in students	3
Planning for TB elimination in Lebanon	3
Epidemiology of tuberculosis among healthcare personnel in New York City	3
Distinctive patterns of pulmonary function change according to baseline lung volume and diffusing capacity	3
Implementing 3HP vs. IPT as TB preventive treatment in Pakistan	3
Epidemiology and risk factors for extrapulmonary tuberculosis in Lebanon	3
Treatment success, but living with the consequences of post-tuberculosis sequelae	3
Using a geographic information system as a management tool for tuberculosis control	3
Diagnostic code agreement for electronic health records and claims data for tuberculosis	3
Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action	3
WHO target product profiles for TB preventive treatment	3
Impact of mental disorders on active TB treatment outcomes: a systematic review and meta-analysis	3
Screening for active and latent TB among migrants in France	3
Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV	3
Symptom and digital chest X-ray TB screening in South African prisons: yield and cost-effectiveness	3
Effect of Global Fund financial support for patients with multidrug-resistant tuberculosis	3
Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis	3
Tuberculosis surveillance in adolescents: what to learn from European Union/European Economic Area data?	3
Patterns of suboptimal adherence among adolescents treated for tuberculosis	3
Presentation and outcome of patients with intracranial tuberculoma in a high HIV prevalence setting	3
What to look for when using SUBsET for subnational TB incidence estimates	3
TB in children and adolescents	3
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali	3
How much does TB screening cost? A systematic review of economic evaluations	3
Epidemiology and clinical characteristics of childhood TB identified using active and passive case finding	3
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	3
Treatment outcomes and safety in children with rifampicin-resistant TB	3
Work-related interstitial lung disease: what is the true burden?	3
Impact of lung function on treatment outcome in patients with TB	3
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens	3
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study	3
Psychological distress among TB patients in sub-Saharan Africa	3
Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study	3
Adapting a TB contact investigation strategy for COVID-19	3
Increase in disseminated TB during the COVID‐19 pandemic	3
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB	3
Introduction of bedaquiline for the treatment of drug-resistant TB in the Philippines	3
Risk factors for the delayed diagnosis of extrapulmonary TB	3
Prevalence and risk factors of tuberculosis disease in South African correctional facilities in 2015	3
Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB	3
Introducing new and repurposed TB drugs: the endTB experience	3
Post-TB bronchiectasis: from pathogenesis to rehabilitation	3
Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan	3
Country differences and determinants of yield in programmatic migrant TB screening in four European countries	3
An assessment of current tuberculosis patient care and support policies in high-burden countries	3
Global Asthma Report 2022: a wake-up call to enhance care and treatment for asthma globally	3
Impact of COVID-19 on TB services in Korea	3
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens	3
Engaging private pharmacies to help end TB in India	3
Ethambutol-induced optic neuropathy in nontuberculous mycobacterial disease	3
TB testing in HIV-positive patients prior to antiretroviral treatment	3
Reference values of impulse oscillometry (IOS) for healthy Indian adults	3
Impact of the COVID-19 pandemic on TB infection testing	3
Determinants of treatment outcomes in patients with multidrug-resistant TB	3
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	3
Undernutrition can no longer be an afterthought for global efforts to eliminate TB	3
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era	3
The impact of smoking on TB treatment outcomes includes recurrent TB	2
Population pharmacokinetics of bedaquiline in patients with drug-resistant TB	2

Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi	2
Clinical effects of TB sequelae in patients with COPD	2
Diabetes mellitus is not a predictor of poor TB treatment outcomes	2
COVID-19 effect on TB presentation and outcome	2
Cost of TB services: approach and summary findings of a multi-country study (Value TB)	2
Cost of TB prevention and treatment in the Philippines in 2017	2
Budget impact of next-generation sequencing for diagnosis of TB drug resistance in Moldova	2
Early mortality during rifampicin-resistant TB treatment	2
eHealth in TB clinical management	2
Can isoniazid preventive therapy be scaled up rapidly? Lessons learned in Kenya, 2014–2018	2
Post-TB lung disease in three African countries	2
Canadian immigrants´ awareness and perceptions of TB infection and TB	2
TB case fatality and recurrence in a private sector cohort in Mumbai, India	2
Latent tuberculosis in pregnant women: a patient perspective	2
TB and COVID-19 coinfection	2
Tuberculin skin test reaction depends on type of purified protein derivative: implications for cut-off values	2
Assessment of knee extensor and flexor function using isokinetic test in COPD: impact on exercise capacity	2
Prevention care cascade in people exposed to drug-resistant TB	2
Costs along the TB diagnostic pathway in Uganda	2
Length of hospital stay for TB varies with comorbidity and hospital location	2
Progress on indoor air quality regulation in India	2
Reporting of interferon-gamma release assay results close to cut-off values	2
Active case‐finding in contacts of people with TB	2
Post-TB disease: a new topic for investigation—and why it matters	2
Evidence for supercoughers in an analysis of six tuberculosis cohorts from China, Peru, The Gambia and Uganda	2
Disease progression in patients with COVID-19: a retrospective cohort study in China	2
Infection status of contacts is not associated with severity of TB in the index case	2
Discovering a new drug is only the beginning: progress and challenges in expanding access to BDQ for MDR-TB treatment	2
A self-rated health score predicts severe disease and high mortality in patients with pulmonary TB	2
Development and validation of novel diagnostic nomogram for tuberculous pleurisy based on TB-IGRA results	2
Disseminated TB in inpatient deaths at a tertiary care centre: an autopsy study over three decades	2
Post-TB outcome science: a sub-discipline for TB survivorship studies?	2
Plasma pharmacokinetics of bedaquiline administered by nasogastric tube in an intensive care unit	2
Whole-genome sequencing differentiates relapse from re-infection in TB	2
Avoiding pitfalls in calculating the population attributable fraction of undernutrition for TB	2
Decline in TB incidence during the COVID-19 pandemic	2
Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus	2
The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London	2
Outdoor air pollution and respiratory health	2
GPT-4, artificial intelligence and implications for publishing	2
Shortening MDR-TB treatment: is treating more patients with fewer drugs better?	2
Pediatric delamanid treatment for children with rifampicin-resistant TB	2
Lack of essential medical resources leaves Africa breathless	2
Post-COVID-19 tomographic abnormalities	2
Call to action for an invigorated drive to scale up TB prevention	2
Expanding the use of dolutegravir-based antiretroviral therapy in multidrug-resistant TB	2
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	2
Uncovering reasons for treatment initiation delays among children with TB in Lima, Peru	2
Concomitant pulmonary disease is common among patients with extrapulmonary TB	2
Successful treatment of patients severely ill with COVID-19	2
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis in China	2
COVID-19 vaccine-induced thrombosis	2
Health-related quality of life of inpatients and outpatients with TB in rural Malawi	2
High‐resolution CT in smoking‐related interstitial lung diseases	2
Caregiver willingness to give TPT to children living with drug-resistant TB patients	2
Efficacy and safety of video-assisted thoracoscopic surgery for pulmonary TB	2
Interferon-gamma release assays for latent tuberculosis infection screening in Canadian federal correctional facilities	2
Health-related quality of life among persons treated for tuberculosis in a European setting	2
Rapid development of a novel portable negative pressure device	2
Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB	2
Sputum culture conversion definitions and analytic practices for multidrug-resistant TB	2
Aspergillus fumigatus-specific antibodies in patients with chronic tuberculosis	2
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting	2
Survey of practices in managing abdominal TB	2
TB prevalence among patients with diabetes in Bangladesh	2
TB in the elderly: clinical features and outcomes	2
Adverse effects and duration of treatment of TB in Canterbury, New Zealand	2
Prevalence of and risk factors for respiratory symptoms in an adult urban population	2
TB reporting declines in priority countries during the COVID-19 pandemic	2
Recent epidemiological trends in extrapulmonary TB in Galicia, Spain	2
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB	2
Use of 3HP for TB preventive treatment in prisons	2
Need for caution when interpreting Xpert® MTB/RIF results for rifampin resistance among children	2
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB	2
Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000–2014	2
TB‐related knowledge and stigma among pregnant women in low‐resource settings	2
Introduction and scaling up of new drugs for drug-resistant TB: experiences from the Americas	2
Introducing bedaquiline: experiences from the Challenge TB Project	2
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	2
Parental TB associated with offspring asthma and rhinitis	2
Finding gaps in routine TB surveillance activities in Bangladesh	2
Understanding the global tuberculosis epidemic: moving towards routine whole-genome sequencing	2
Airflow limitation as a risk factor for vascular stiffness	2
Long-term mortality of patients with tuberculosis in Korea	2
Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis	2
TB consilia and quality of tuberculosis management	2
Financial impact of COVID-19 on TB patients in India	2
Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting	2
Overcoming barriers to the access and uptake of newer drugs for multidrug-resistant TB	2
Characteristics, risk factors and outcomes of critically ill patients with active TB	2
Digital adherence technology for TB: focus on livelihoods as well as lives	2
The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia	1
The economic burden of TB-affected households in DR Congo	1
Xpert Ultra in diagnosing extrapulmonary TB: accuracy and trace calls	1
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease	1
Down Syndrome and COVID-19: not always a poor prognosis	1
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	1
A roadmap for lifting restrictive measures for COVID-19	1
Idiopathic and post-infectious bronchiectasis: take care with the diagnosis!	1
Aspergillus infection is an important complication of post-TB bronchiectasis	1
Key messages and partnerships to raise awareness and improve outcomes for people with asthma and COPD in low- and middle-income countries	1
Benefits of community-based TB screening vs. passive case finding	1
Occupational safety and health for respiratory health: a comprehensive approach for an often-forgotten issue	1
TB stigma and its correlates among HIV-positive people who inject drugs in Ukraine	1
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	1
Reducing the burden of TB among migrants to low TB incidence countries	1
An approach for improving the quality of country-level TB modelling	1
Evaluation of point-of-care algorithms to detect diabetes during screening for latent TB infection	1
High prevalence of pre-diabetes among people living with HIV in a high TB burden setting	1
Diagnostic performance of whole-genome sequencing for identifying drug-resistant TB in Thailand	1
Completeness of TB notification in Portugal, 2015: an inventory and capture-recapture study	1
TB screening, prevention and treatment cascade in a Malawi prison	1
Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data	1
Why TB programmes should assess for comorbidities, determinants and disability at the start and end of TB treatment	1
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	1
Prevalence of COPD among women and relation with cooking fuel choice in Ouagadougou, Burkina Faso	1
Feasibility and acceptability of asynchronous VOT among patients with MDR-TB	1
Where next with for vitamin D and tuberculosis?	1
A scoping review of interventions to mitigate common non-communicable diseases among people with TB	1
Role of symptom and chest X-ray screening in evaluating child household contacts for pulmonary TB	1
Referral of presumptive TB among operators of community medicine outlets	1
TB and chronic pulmonary aspergillosis: a few relevant points	1
Global availability of susceptibility testing for second-line anti-tuberculosis agents	1
Hospitalizations with TB, California, 2009–2017	1
Pulmonary TB and chronic pulmonary aspergillosis	1
The need for effective drugs for TB prevention: set your goals high, and don´t stop till you get there	1
Updated guidelines for child and adolescent TB	1
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB	1
Tuberculosis surveillance and its discontents: the ethical paradox	1
Culture-negative TB: clinical characteristics, risk factors and treatment outcomes	1
Determinants of non-adherence to anti-TB treatment in high income, low TB incidence settings: a scoping review	1
Tuberculosis in a Spanish cohort of children living with HIV: the CHOTIS study (Childhood HIV & TB study)	1
Surgical treatment for non-tuberculous mycobacterial pulmonary disease: analysis of prognostic factors	1
Influence of type of dwelling on the prevalence of chronic respiratory diseases in Ho Chi Minh City, Viet Nam	1
Down syndrome and COVID-19, a combination with a poor prognosis	1
The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB	1
Hope rises out of despair: bedaquiline and linezolid for the treatment of drug-resistant TB	1
TB diagnosis and treatment during the COVID-19 pandemic	1
One third of child TB cases were missing from the national TB register in Botswana	1
The importance of pharmacokinetics/pharmacodynamics assessment in Phase IIB/III trials for MDR-TB treatment	1
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	1
Isolation and purification of lipoarabinomannan from urine of adults with active TB	1
Best practices for the care of pregnant people living with TB	1
Beyond measurement: taking bold multisector actions towards zero catastrophic costs and suffering due to TB	1
Stress, asthma and allergic sensitisation to house dust mite in children	1
Bridging the gap: key evidence needed to strengthen global policies to end TB	1
TB and COVID-19 in migrants – the need to focus on both conditions	1
Time to care-seeking for TB symptoms	1
Measuring anti-TB drug concentrations in hair: unlocking the door to cumulative drug exposure and treatment outcome	1
Airways flow limitation in symptomatic adult cannabis smokers	1
Nosocomial TB in two neonatal intensive care units at a tertiary care centre: infection risk and outcomes	1
Multidrug-resistant tuberculosis care in the United States	1
Over the limit: tuberculosis and excessive alcohol use	1
Impact of COVID-19 on TB detection in the private sector in Nepal	1
Assessment of TB treatment on patient well-being	1
Geospatial analysis and factors associated with poor outcome for multidrug-resistant tuberculosis	1
Trends in rifampicin and isoniazid resistance in patients with presumptive TB	1
Finding the right balance between efficacy and tolerability for TB treatment: the search continues	1
Financial support to the poor for the detection of smear-negative pulmonary and extra-pulmonary TB in Bangladesh	1
Effectiveness of two tobacco cessation methods among TB patients	1
TB and women: a call to action	1
Computer-assisted interpretation of chest radiographs: signs of hope for silicosis and tuberculosis	1
Why are people still dying of drug-susceptible TB in Paris in the 21st century?	1
Uptake of the lateral flow urine LAM test in Europe and Central Asia	1
Assessment of asthma control in users of oral anti-asthma medications	1
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19	1
Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies	1
Immune response against TB and non-tuberculous mycobacterial pulmonary disease	1
Non-tuberculous mycobacteria in sputum cultures in Suriname	1
Reflecting on the relationship between residential schools and TB in Canada	1
One size does not fit all: reaching agricultural workers in South Africa with TB services	1
Diagnosis of paediatric TB using Xpert® MTB/RIF Ultra on fresh respiratory samples	1
Prevalence and risk factors of airflow obstruction in a Caribbean population	1
Targeted TB control in migrants to low-burden countries	1
Demographic and socio-economic risk factors associated with self-reported TB	1
ScreenTB: a tool for prioritising risk groups and selecting algorithms for screening for active tuberculosis	1
Improving enrolment for TB preventive treatment	1
Evaluation of QFT-Plus performance using blood samples stored at room temperature	1
User perspectives on the use of X-rays and computer-aided detection for TB	1
Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert® MTB/RIF	1
The importance of knowing why TB patients stop anti-TB treatment	1
Improving outcomes for multidrug-resistant TB treatment	1
Use of interactive messaging to reduce pre-diagnosis loss to follow-up for TB care	1
Effectiveness of a community-based intervention to prevent childhood TB in Lesotho	1
Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial	1
The environment is a first order issue for lung health	1
The acquisition of Mycobacterium tuberculosis infection in village doctors in China: a prospective study	1
Indoor pet allergen exposures modify the effects of chemical air pollutants on respiratory symptoms	1
Flupentixol/melitracen for chronic refractory cough after treatment failure with other neuromodulators	1
Strategic approach to optimisation of TB contact investigation in Nigeria	1
Advancing TB research using digitized programmatic data	1
What will it take to achieve meaningful action on tuberculosis among Indigenous Peoples?	1
The economic burden of TB faced by patients and affected families in Papua New Guinea	1
Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB	1
War in Ukraine and the TB epidemic	1
Recent developments in the diagnosis and treatment of extrapulmonary non-tuberculous mycobacterial diseases	1
From Peruvian mummies to living humans: first case of pulmonary tuberculosis caused by Mycobacterium pinnipedii	1
Potential drug–drug interactions among hospitalised TB patients	1
Use of chest radiography screening for TB: a re-evaluation of the Kolín study	1
Dactylitis due to accidental needle-stick injury with a BCG-loaded syringe	1